BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26527862)

  • 21. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.
    Liang Z; Wu T; Lou H; Yu X; Taichman RS; Lau SK; Nie S; Umbreit J; Shim H
    Cancer Res; 2004 Jun; 64(12):4302-8. PubMed ID: 15205345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.
    Tamamura H; Hori A; Kanzaki N; Hiramatsu K; Mizumoto M; Nakashima H; Yamamoto N; Otaka A; Fujii N
    FEBS Lett; 2003 Aug; 550(1-3):79-83. PubMed ID: 12935890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.
    Zhang T; Li J; Dong Y; Zhai D; Lai L; Dai F; Deng H; Chen Y; Liu M; Yi Z
    Breast Cancer Res Treat; 2012 Sep; 135(2):445-58. PubMed ID: 22842972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
    Young AI; Law AM; Castillo L; Chong S; Cullen HD; Koehler M; Herzog S; Brummer T; Lee EF; Fairlie WD; Lucas MC; Herrmann D; Allam A; Timpson P; Watkins DN; Millar EK; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR
    Breast Cancer Res; 2016 Dec; 18(1):125. PubMed ID: 27931239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
    Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
    Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Embelin Inhibits Invasion and Migration of MDA-MB-231 Breast Cancer Cells by Suppression of CXC Chemokine Receptor 4, Matrix Metalloproteinases-9/2, and Epithelial-Mesenchymal Transition.
    Lee H; Ko JH; Baek SH; Nam D; Lee SG; Lee J; Yang WM; Um JY; Kim SH; Shim BS; Ahn KS
    Phytother Res; 2016 Jun; 30(6):1021-32. PubMed ID: 27030214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aloperine inhibits proliferation, migration and invasion and induces apoptosis by blocking the Ras signaling pathway in human breast cancer cells.
    Tian D; Li Y; Li X; Tian Z
    Mol Med Rep; 2018 Oct; 18(4):3699-3710. PubMed ID: 30132540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibitory effect of viral macrophage inflammatory protein-II on metastasis of breast cancer cell line MCF-7 through antagonising CXCR4].
    Liu FJ; Sun HX
    Ai Zheng; 2004 Nov; 23(11):1283-7. PubMed ID: 15522174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models.
    Peng SB; Zhang X; Paul D; Kays LM; Gough W; Stewart J; Uhlik MT; Chen Q; Hui YH; Zamek-Gliszczynski MJ; Wijsman JA; Credille KM; Yan LZ
    Mol Cancer Ther; 2015 Feb; 14(2):480-90. PubMed ID: 25504752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
    Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adeno-associated virus-mediated expression of recombinant CBD-HepII polypeptide of human fibronectin inhibits metastasis of breast cancer.
    He ZH; Lei Z; Zhen Y; Gong W; Huang B; Yuan Y; Zhang GM; Wang XJ; Feng ZH
    Breast Cancer Res Treat; 2014 Jan; 143(1):33-45. PubMed ID: 24288120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pomolic Acid Inhibits Invasion of Breast Cancer Cells Through the Suppression of CXC Chemokine Receptor Type 4 Expression.
    Kim B; Kim JH; Park B
    J Cell Biochem; 2016 Jun; 117(6):1296-307. PubMed ID: 26495998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo inhibition of bone morphogenetic protein-2 on breast cancer cell growth.
    Ye S; Park BH; Song KJ; Kim JR; Jang KY; Park HS; Bae JS; Brochmann EJ; Wang JC; Murray SS; Lee KB
    Spine (Phila Pa 1976); 2013 Feb; 38(3):E143-50. PubMed ID: 23169070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
    Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
    J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts.
    Al Marzouqi N; Iratni R; Nemmar A; Arafat K; Ahmed Al Sultan M; Yasin J; Collin P; Mester J; Adrian TE; Attoub S
    Eur J Pharmacol; 2011 Oct; 668(1-2):25-34. PubMed ID: 21741966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.